i-Pharm GxP’s Post

The need for international partnerships and cross-border teamwork has proven crucial to successful research and development in life sciences. But, how exactly does global collaboration impact drug development? We’ve had a look at some of the key areas where global collaboration is making a key different in the development of new treatments and medicines in life sciences: 🧬 Enhanced clinical trials�� Conducting clinical trials on a global scale provides access to a broader and more diverse patient population. This diversity helps develop treatments that are effective across different genetic backgrounds and demographics, ultimately leading to more inclusive and universally applicable therapies. 🤝 Growth of knowledge  International partnerships enable the sharing of knowledge and best practices across borders. By learning from each other’s successes and challenges, organisations can avoid common pitfalls, streamline processes, and adopt innovative approaches that have been proven effective elsewhere. 📉 Reduced costs and risks  By sharing financial and logistical burdens, companies can undertake more ambitious projects without bearing the full weight of potential failures alone. This collaborative approach makes it feasible to explore high-risk, high-reward research avenues. With global collaboration on the rise in our industry, where do you think this will have the biggest impact? Leave your thoughts in the comments below and stay tuned for a poll coming to our page soon! #lifesciences #globalcollaboration #iPharmGxP

🔍 How do multinational enterprises search for and manage distant collaboration with academia? How do social ties and personal linkages influence these processeses? What is the role of corporate strategies? These are some of the questions raised by Claudio Fassio in today’s Research Talk. 💬 After his presentation on “Global search for science: A case study of AstraZeneca”, Claudio engaged in a Q&A session discussing how best to operationalise and measure the mechanisms under consideration, the benefits of including a network evolution analysis, and managerial implications of such research. 🙏 Thank you, Claudio, for an interesting dive into cross-sectoral collaboration dynamics! And thanks to our attendees for their insightful comments and contributions! #CrossSectoralCollaboration #Innovation

Having spoken to another business owner this week who specialises in Life Sciences and Clinical Development, it's evident that the market conditions of 2023 have brought about challenges within our industry. Whether you're a smaller biotech start-up, a niche CRO, or a global development organization, the reverberations of reduced investment channels in early-stage research have been universally felt. Yet, amid these challenges, there are always some silver linings that are illuminating our path forward. There's are glimmers of momentum gaining traction both in the USA and Europe – a promising sign that our industry's resilience remains.. The momentum of increasing requirements signifies a renewed appetite for innovation and advancement. Yes, there's an air of caution from our clients and the candidates considering a move as we navigate these transformative times. The road to stability can often be met with challenges, but it's also paved with opportunities for growth and transformation. So to anyone who has found themselves in a difficult position, out of work, or finding it hard to see the light at the end of the first half of 2023, let's keep our focus on the natural evolution of change, embrace the challenge and look ahead with optimism for what will come. If you are in need of help in anyway, to learn more about the market conditions, find a new challenge, hire your next superstar, or just want an informal chat, then please get in touch at info@ccs-global.com..... 🌟🌍 #LifeSciences #ClinicalDevelopment #2023-ChallengeAccepted CCS-Global #Empoweringclinicaltrialdelivery

Finalising a highly diverse scientific- and medical week by attending an intriguing fireside chat with Dr. Robert Langer. Having my grounds profoundly in global pharma, it was highly interesting listening to the vast perspectives of current and coming biotech, perspectives of science, leadership, when to take chances, cultural aspects of failures and what is perceived as the most desirable mindset for succeeding in bringing innovative biotech to impactful contributions on a global scale. To the many early stage biotech founders and early stage CEOs, whom were also attending and eager to harvest important points on how to build their companies, his take home message was very clear: “Hire people whom will go through walls to get things done and whom are NICE”. I applaud this statement, as it so impactful translates into every single aspect of an organisation, into leadership impact, and into teamwork. A fireside chat with nostalgic strings to my own early scientific days, to current clients and as an inspiring prelude of what is to come. GLOBAL IMPACT & ELITE EXECUTIVE ADVISORY   Global Elite Performance / Global Elite Talent Development / Global Impact Career Development in LIFE, Health & Medical Sciences   Copenhagen Based - Working Worldwide #collaboration #globalpharma #pharma #biotech #executiveadvisor #trustedadvisor #eliteperformance #lifesciences #life #health #medical #sciences #healthcare You are welcome to follow, connect, or reach out

Check this program out Pharma peeps! Having perspective on Neurodiversity is more than a good thing for High-Performing Pharma teams and in this ever changing world of Pharma sales and sales in general for that matter!

Today Advanced Therapies ExCel showcased the best in developing our workforce delivering advanced therapies to patients. I am fortunate to work with organisations like the BioIndustry Association (BIA) that promote DEI and support member organisations develop their best talent. Incredible panel sessions included: 🚀 Where Are All The Women in Leadership - a workshop bursting at the seams with female talent hosted by The CGT Circle co-founder Nicola Ambler and panelists Anji Miller Ph.D CLP RTTP Amélie Quilichini Katy Newton and Jason Jones. Key takeaways were to call out those behaviours that still exist, lift each other up and push forward for change. Networks are vital, mentors essential and differences valued. 🚀 DEI in Advanced Therapies - How Can We Improve Diversity & Representation At All Levels. Brilliant discussion about attraction diverse talent early and supporting through their career, why diversity and inclusion are s important in delivering innovative therapies to patients and the role of real inclusion delivering high performing teams. Brilliant panel Lindsey Clarke Anji Miller Ph.D CLP RTTP James Kusena PhD Krisha Patel 🚀 Addressing The Education & Training Needs of an ATMP Workforce - yet again the incredible Anji Miller Ph.D CLP RTTP Ivan Wall Pamela Tranter and Montserrat Deban of Biocat, BioRegion of Catalonia - unique challenges include; translation skills for early career researchers to develop their processes earlier, regulatory skills and understanding of pricing, complexity of multiple manufacturing processes and automation, complexity of roles and career pathways. So what can we all do: ▪︎ Evidence skills & diversity gaps ▪︎ Fund & deliver collaborative solutions ▪︎ Invest in ourselves & build networks ▪︎ Avoid overlap & work with what exists ▪︎ Innovate with funded apprenticeships ▪︎ Lead by example & mentor new talent

👉 Are you tired of hearing about the gap between academia and industry? Well, here's some good news! 🎉 Let's talk about how academia and industry collaboration can revolutionize drug discovery. 💡 👉 Bridging 🔗 the gap: By joining forces, academia and industry can combine their unique strengths to streamline the drug discovery process. Imagine a world where scientific research is seamlessly translated into life-saving treatments. 👉 Cutting-edge technology at your fingertips 👨💻: Industry brings expertise in high-throughput screening, automation, and big data analysis. Academic researchers can access these resources and utilize them to accelerate their studies, maximizing efficiency and productivity. 👉 Unleashing innovation 💥: Collaboration sparks new ideas and creativity. When academia and industry intertwine their respective knowledge bases, breakthroughs happen! The synergy of experts from diverse backgrounds fosters innovation that benefits patients worldwide. 👉 From bench to bedside 🏥: In this fruitful partnership, academic discoveries get fast-tracked for clinical trials, shortening the time it takes to bring life-changing therapies to patients who need them most urgently. 👉 Shaping future leaders 🌟: Collaborative projects provide valuable training opportunities for young scientists. By actively participating in both academic and industrial environments, they develop a versatile skill set that empowers them as leaders in healthcare research. ✨ Ready to bridge the gap together? Join the movement! Let's foster even stronger collaborations between academia and industry for accelerated drug discovery. Drop a comment below if you're already involved or tag someone who should be! #AcademiaIndustryCollaboration #DrugDiscoveryRevolution #TogetherWeCanDoMore

Did you know that the UK has a dynamic world of life sciences #innovation? We are just as excited about that as the head of Innovate UK – Indro Mukerjee – who praises the organisation’s engagement with innovators ahead of his keynote speech at next week’s Scottish Life Sciences Summit. Innovate UK is fostering #collaboration, accessibility and #growth opportunities nationwide. From the £40m Opportunity North East (ONE) BioHub in to partnerships with higher education institutions like the University of Aberdeen, the UK's life sciences clusters are booming. Read this article to discover how companies like Elasmogen and TauRx Pharmaceuticals are thriving in Aberdeen's vibrant life sciences cluster, attracting global talent and investment: https://ow.ly/UVT050QWplB #LifeSciences #Innovation #UKClusters #EconomicGrowth #SocietalImpact

Are you a UK-based med-tech or biotech business owner seeking to expand your business across Europe? Go To Market Global with Innovaud Department for Business and Trade is hosting an online workshop: Innovaud Life Sciences UK Mission – Cambridge & London 📆𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟱-𝟲, 𝟮𝟬𝟮𝟯 This workshop is tailored for UK owner-managed #medtech devices and #biotech, these interactive panel and 1-2-1 connector events in London & Cambridge will give you valuable insights on: 💡𝗨𝗻𝗶𝗾𝘂𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺 – ‘Health Valley’ from innovative start-ups to scale-ups and major corporates. 💡𝗪𝗼𝗿𝗹𝗱-𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝗥&𝗗 𝗮𝗰𝗰𝗲𝘀𝘀 𝗮𝗻𝗱 𝘁𝗵𝗼𝘂𝗴𝗵𝘁 𝗹𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 – EPFL, Biopôle, The Swiss Cancer Centre, Lausanne, CHUV and the Y-PARC. 💡𝗔𝘂𝘁𝗵𝗲𝗻𝘁𝗶𝗰𝗮𝘁𝗲 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗮𝗻𝗱 𝗽𝗮𝘁𝗵𝘄𝗮𝘆𝘀 – from the greatest life sciences talent pool in Europe 💡𝗔𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗴𝗿𝗮𝗻𝘁𝘀, 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 𝗮𝗻𝗱 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 – from bilateral R&D grants, the unique Swiss Offset programme to venture capital and major corporate investment channels. 💡𝗧𝗼𝗽 𝗥𝗮𝗻𝗸𝗲𝗱 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗹𝗶𝗳𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗱𝗲𝘀𝘁𝗶𝗻𝗮𝘁𝗶𝗼𝗻 – Ranked No. 1 in the European Health Consumer Index, Switzerland is the best in terms of accessibility, health outcomes, and staffing, with a healthcare system that is neither tax-based nor financed by employers. 💡𝗔 𝗽𝗿𝗼-𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀, 𝘁𝗮𝗿𝗶𝗳𝗳-𝗳𝗿𝗲𝗲 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗲𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁 – the recent negotiations between the Swiss and UK governments only enhance the opportunities for growth and investment. gigCMO has been a global marketing partner of Go To Market Global since 2021. At gigCMO, we help businesses like yours achieve your business goals by providing you with strategic guidance, expert marketing insights, and tailored solutions to achieve your business goals. 🎯 𝗗𝗼𝗻'𝘁 𝗺𝗶𝘀𝘀 𝘁𝗵𝗶𝘀 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆! 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗵𝗲𝗿𝗲: https://lnkd.in/eR5HjvyS #InnovaudLifeSciences #GlobalExpansion #BusinessGrowth #GTMGlobal #networking #partnerships #opportunities

🚀 Embarking on a Dynamic Business Journey Across Borders 🚀 📅 October 8th to October 13th, 2023 📅 Fellow professionals, the upcoming week unfolds a vibrant tapestry of meaningful connections, knowledge sharing, and invaluable discussions as I traverse through six pivotal cities in North America! 🇺🇸🇨🇦 📍 Destinations: Los Angeles 🎥 Anaheim 🏰 San Francisco 🌉 Calgary 🏔️ Toronto 🍁 New York 🗽 🤝 Meetings: Engaging with esteemed #Clients, promising #Prospects, and potential partners, our dialogues will delve deep into the realms of #Reimbursement, #HealthEconomics, and #PricingStrategies in the medical technologies and pharmaceutical sectors. 💊🔬 🎤 Conference Attendance: Thrilled to absorb and exchange insights at a pivotal conference, where thought leaders, innovators, and industry experts converge to sculpt the future of #MedicalTechnology and #Pharmaceuticals. 🚀💡 🔄 The Core Focus: ➡️ Navigating through the multifaceted aspects of reimbursement models. ➡️ Unraveling the economic impacts on healthcare and drug development. ➡️ Sculpting equitable and sustainable pricing strategies. 🔗 Let’s Connect! If you’re in any of these cities and resonate with these topics, I would be thrilled to explore synergies, share insights, and possibly meet over a coffee ☕ or a virtual chat! 🖥️ 🚪 Opening Doors to Collaboration: Your thoughts, experiences, and insights are invaluable. Whether we’re able to meet in person or connect virtually, let’s ensure that the dialogue continues, shaping a future where healthcare is accessible, innovative, and economically balanced. 🌐🤝 📍 Your insights matter! Drop a comment, DM, or simply a ‘🚀’ below if you’re excited about forging paths toward impactful healthcare solutions! 💭👇 #BusinessTrip #MedicalInnovation #HealthcareEconomics #ClientMeetings #StrategicPricing #CrossBorderCollaborations #PharmaEconomics #HealthTech #GlobalHealthcare